Search

Yes! CBD Is Helpful For Anxiety!


CBD FOR ANXIETY

While THC or tetrahydrocannabinol is responsible for boosting the symptoms of anxiety, CBD or cannabidiol seems to be quite helpful for reducing different types of anxiety disorders. It is also helpful for generalized anxiety disorder, and social anxiety.


CBD for Anxiety

Studies have shown that CBD can interact with human endocannabinoid system. Just like many other essential physiological functions, ECS is also responsible for regulating mood and improving the fight and flight mode of the body. CBD can interact with the receptors of the endocannabinoid system which are spread all across the body. Not only this, CBD can also interact with the 5HTV1 serotonin receptors. Serotonin is an important neurotransmitter that is responsible for inducing happy feelings along with some other important functions. The interaction of the cannabinoids with the ECS and serotonin receptors makes it helpful for reducing the symptoms of anxiety.


Right CBD Dose for Anxiety

Study conducted in 2019 has shown that CBD dose-ranging between 25 to 150 mg can be very helpful for reducing the symptoms of anxiety. However, the effectiveness of the dose depends on the severity of the symptoms .


How to Used CBD for Anxiety?

Golden Glow CBD products are available in numerous forms for anxiety. Our most popular products for anxiety are the following our Infused Tinctures, Soft Gels and Gummies.



References

Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., ... & Hallak, J. E. C. (2011). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Journal of psychopharmacology, 25(1), 121-130.

Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836.

Skelley, J. W., Deas, C. M., Curren, Z., & Ennis, J. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association, 60(1), 253-261.

12 views0 comments

Recent Posts

See All